Clinical Trial Update: A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）

View source ↗

Summary

Beckman Coulter completed a study evaluating cut-off values for N-terminal brain natriuretic peptide (NT-proBNP) using a chemiluminescence method in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndromes
• Heart Failure

Snippet

Sponsor: Beckman Coulter, Inc. | Conditions: Heart Failure, Acute Coronary Syndromes | Status: COMPLETED